Det vides ikke, om icatibant udskilles i human modermælk, men det anbefales, at ammende kvinder, der tager Firazyr, ikke ammer i 12 timer efter indgiften.
It is unknown whether icatibant is excreted in human breast milk but it is recommended that breastfeeding women, who wish to take Firazyr, should not breastfeed for 12 hours after treatment.